GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shine-On BioMedical Co Ltd (ROCO:6926) » Definitions » Shares Outstanding (EOP)

Shine-On BioMedical Co (ROCO:6926) Shares Outstanding (EOP) : 49.69 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Shine-On BioMedical Co Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Shine-On BioMedical Co's shares outstanding for the quarter that ended in Dec. 2024 was 49.69 Mil.

Shine-On BioMedical Co's quarterly shares outstanding declined from Jun. 2024 (49.80 Mil) to Dec. 2024 (49.69 Mil). It means Shine-On BioMedical Co bought back shares from Jun. 2024 to Dec. 2024 .

Shine-On BioMedical Co's annual shares outstanding declined from Dec. 2023 (49.80 Mil) to Dec. 2024 (49.75 Mil). It means Shine-On BioMedical Co bought back shares from Dec. 2023 to Dec. 2024 .


Shine-On BioMedical Co Shares Outstanding (EOP) Historical Data

The historical data trend for Shine-On BioMedical Co's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shine-On BioMedical Co Shares Outstanding (EOP) Chart

Shine-On BioMedical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shares Outstanding (EOP)
Get a 7-Day Free Trial 43.00 18.47 49.80 49.80 49.75

Shine-On BioMedical Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.80 49.80 49.80 49.80 49.69

Competitive Comparison of Shine-On BioMedical Co's Shares Outstanding (EOP)

For the Biotechnology subindustry, Shine-On BioMedical Co's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shine-On BioMedical Co's Shares Outstanding (EOP) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shine-On BioMedical Co's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Shine-On BioMedical Co's Shares Outstanding (EOP) falls into.


;
;

Shine-On BioMedical Co Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Shine-On BioMedical Co  (ROCO:6926) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Shine-On BioMedical Co Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Shine-On BioMedical Co's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Shine-On BioMedical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 633, Section 2, Taiwan Avenue, Unit 6, 5th Floor, Xitun District, Taichung, TWN
Shine-On BioMedical Co Ltd develops drugs based on antibodies and nucleic acids. The Company researches, develops, manufactures, and distributes antibody anticancer drugs, nucleic acid anticancer drugs. The company's drug development and nucleic acid therapeutics are focused on providing patients with the most effective cancer treatment options.

Shine-On BioMedical Co Headlines

No Headlines